Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ovarian Carcinosarcoma × dostarlimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Neoplasms 14 Endometrial Neoplasms 14 Carcinoma, Non-Small-Cell Lung 9 Ovarian Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Melanoma 4 Colonic Neoplasms 4 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Breast Neoplasms 3 Stomach Neoplasms 2 Osteosarcoma 2 Multiple Myeloma 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Neuroendocrine 2 Carcinoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma, Clear Cell 1 Sarcoma 1

Interventions

niraparib 1 dostarlimab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03651206 2025-12-19

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡